The purpose of the study is to determine the safety, tolerability and pharmacokinetics of
zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers
- Male and female subjects between the ages of 18 to 55 years, inclusive who are in
good general health
- Subjects with a history of allergy or intolerance to zaleplon. Subjects who have any
other disease or condition, by history, physical examination, or laboratory
abnormalities that in the investigator's opinion, would present undue risk to the
subject, or may confound the interpretation of study results.